Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenotypes of organ involvement in sarcoidosis.
Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O'Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O'Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J. Schupp JC, et al. Among authors: jovanovic d. Eur Respir J. 2018 Jan 25;51(1):1700991. doi: 10.1183/13993003.00991-2017. Print 2018 Jan. Eur Respir J. 2018. PMID: 29371378 Free article.
Pulmonary sarcoidosis.
Mihailovic-Vucinic V, Jovanovic D. Mihailovic-Vucinic V, et al. Among authors: jovanovic d. Clin Chest Med. 2008 Sep;29(3):459-73, viii-ix. doi: 10.1016/j.ccm.2008.03.002. Clin Chest Med. 2008. PMID: 18539238 Review.
Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.
Fischer A, Ellinghaus D, Nutsua M, Hofmann S, Montgomery CG, Iannuzzi MC, Rybicki BA, Petrek M, Mrazek F, Pabst S, Grohé C, Grunewald J, Ronninger M, Eklund A, Padyukov L, Mihailovic-Vucinic V, Jovanovic D, Sterclova M, Homolka J, Nöthen MM, Herms S, Gieger C, Strauch K, Winkelmann J, Boehm BO, Brand S, Büning C, Schürmann M, Ellinghaus E, Baurecht H, Lieb W, Nebel A, Müller-Quernheim J, Franke A, Schreiber S; GenPhenReSa Consortium. Fischer A, et al. Among authors: jovanovic d. Am J Respir Crit Care Med. 2015 Sep 15;192(6):727-36. doi: 10.1164/rccm.201503-0418OC. Am J Respir Crit Care Med. 2015. PMID: 26051272 Free PMC article.
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis.
Tran T, Šterclová M, Mogulkoc N, Lewandowska K, Müller V, Hájková M, Kramer MR, Jovanović D, Tekavec-Trkanjec J, Studnicka M, Stoeva N, Hejduk K, Dušek L, Suissa S, Vašáková M; EMPIRE registry. Tran T, et al. Among authors: jovanovic d. Respir Res. 2020 Jan 8;21(1):11. doi: 10.1186/s12931-019-1271-z. Respir Res. 2020. PMID: 31915023 Free PMC article.
Verifying Sarcoidosis Activity: Chitotriosidase versus ACE in Sarcoidosis - a Case-control Study.
Popević S, Šumarac Z, Jovanović D, Babić D, Stjepanović M, Jovičić S, Šobić-Šaranović D, Filipović S, Gvozdenović B, Omčikus M, Milovanović A, Videnović-Ivanov J, Radović A, Žugić V, Mihailović-Vučinić V. Popević S, et al. Among authors: jovanovic d. J Med Biochem. 2016 Nov 2;35(4):390-400. doi: 10.1515/jomb-2016-0017. eCollection 2016 Oct. J Med Biochem. 2016. PMID: 28670191 Free PMC article.
Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE.
Kolonics-Farkas AM, Šterclová M, Mogulkoc N, Kus J, Hájková M, Müller V, Jovanovic D, Tekavec-Trkanjec J, Littnerová S, Hejduk K, Vašáková M. Kolonics-Farkas AM, et al. Among authors: jovanovic d. Drug Saf. 2020 Oct;43(10):971-980. doi: 10.1007/s40264-020-00978-5. Drug Saf. 2020. PMID: 32734423 Free PMC article.
Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries.
Kolonics-Farkas AM, Šterclová M, Mogulkoc N, Lewandowska K, Müller V, Hájková M, Kramer M, Jovanovic D, Tekavec-Trkanjec J, Studnicka M, Stoeva N, Littnerová S, Vašáková M. Kolonics-Farkas AM, et al. Among authors: jovanovic d. Front Med (Lausanne). 2021 Dec 23;8:729203. doi: 10.3389/fmed.2021.729203. eCollection 2021. Front Med (Lausanne). 2021. PMID: 35004713 Free PMC article.
Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.
Májek O, Gregor J, Mogulkoć N, Lewandowska K, Šterclová M, Müller V, Hájková M, Kramer MR, Tekavec-Trkanjec J, Jovanović D, Studnicka M, Stoeva N, Kirchgässler KU, Littnerová S, Dušek L, Vašáková MK. Májek O, et al. Among authors: jovanovic d. PLoS One. 2022 Sep 1;17(9):e0273854. doi: 10.1371/journal.pone.0273854. eCollection 2022. PLoS One. 2022. PMID: 36048805 Free PMC article.
728 results